Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

CEO Albert Bourla told investors Tuesday morning that he is “cautiously optimistic” about working with Robert F. Kennedy Jr., ...

The pharma executive is optimistic about the new US administration but is also realistic about the risks that come with "radical change." ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump ...

Trump has not yet outlined specific health policy plans ... I guess we'll see," Pfizer CEO Albert Bourla said during a ...

SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He admitted that after the company made a “big miscalculation” around ...

Its high debt load remained a cause of investor concern for the entire year, and as a result, CEO Albert ... Dr. Bourla’s relationship and potential meeting with President-elect Trump ...

It’s not just the tech billionaires descending on Washington. Plenty of chief executives from other industries are also attending the inauguration and its related events, as corporate America [looks t ...

President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla. In his first term, Trump championed the $18 billion Operation Warp Speed ...